USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $90.00-100.00 / Milligram
USD $8.00-22.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $50.00-70.00 / Kilogram
empagliflozin basic information |
product name: | empagliflozin |
synonyms: | empagliflozin;bi-10773;(1s)-1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-d-glucitol;empagliflozin/ bi-10773;empagliflbzin;(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2h-pyran-3,4,5-triol;d-glucitol, 1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]m ethyl]phenyl]-, (1s)-;(1s)-1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-d-glucitol empagliflozin bi 10773 |
cas: | 864070-44-0 |
mf: | c23h27clo7 |
mw: | 450.90928 |
einecs: | |
product categories: | api;inhibitors |
mol file: | 864070-44-0.mol |
empagliflozin chemical properties |
bp | 665℃ |
density | 1.398 |
fp | 356℃ |
safety information |
empagliflozin usage and synthesis |
usage | empagliflozin is a novel, potent and selective sglt-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats. |
empagliflozin basic information |
product name: | empagliflozin |
synonyms: | empagliflozin;bi-10773;(1s)-1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-d-glucitol;empagliflozin/ bi-10773;empagliflbzin;(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2h-pyran-3,4,5-triol;d-glucitol, 1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]m ethyl]phenyl]-, (1s)-;(1s)-1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-d-glucitol empagliflozin bi 10773 |
cas: | 864070-44-0 |
mf: | c23h27clo7 |
mw: | 450.90928 |
einecs: | |
product categories: | api;inhibitors |
mol file: | 864070-44-0.mol |
empagliflozin chemical properties |
bp | 665℃ |
density | 1.398 |
fp | 356℃ |
safety information |
empagliflozin usage and synthesis |
usage | empagliflozin is a novel, potent and selective sglt-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats. |
empagliflozin basic information |
product name: | empagliflozin |
synonyms: | empagliflozin;bi-10773;(1s)-1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-d-glucitol;empagliflozin/ bi-10773;empagliflbzin;(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2h-pyran-3,4,5-triol;d-glucitol, 1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]m ethyl]phenyl]-, (1s)-;(1s)-1,5-anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-d-glucitol empagliflozin bi 10773 |
cas: | 864070-44-0 |
mf: | c23h27clo7 |
mw: | 450.90928 |
einecs: | |
product categories: | api;inhibitors |
mol file: | 864070-44-0.mol |
empagliflozin chemical properties |
bp | 665℃ |
density | 1.398 |
fp | 356℃ |
safety information |
empagliflozin usage and synthesis |
usage | empagliflozin is a novel, potent and selective sglt-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats. |